If the coronovirus vaccination is widely applied, life could return to “normal” by next winter, one of the scientists behind the leading coronavirus vaccine said on Sunday.
The Turkish co-founder of German company Bayonne, Ugur Sahin, told the BBC’s Andrew Marr Show that “this winter will be tough” without any major impact from vaccination.
Together with veteran American Pfizer, BioN is developing a leading candidate for the global vaccine.
“If all goes well, we will start administering the vaccine at the end of this year or the beginning of next year,” Sahin said.
“Our goal is to deliver more than 300 million doses by April next year, which could already have an impact,” he said.
In summer, the infection rate will decrease, he predicted, adding that it is necessary to have a higher vaccination place in the fall.
“I believe it will happen,” he said.
Several vaccination companies are working to increase the supply, he said: “So we can get a cold next year (year).”
Sahin and his wife Ozlem Turiski founded Bayonet in the West German city of Mainz in 2008.
After identifying the promising vaccine model, the company partnered with US pharmaceutical giant Pfizer in March.
It was announced on Monday that his vaccine was over 90% effective in newsletters around the world and sent it to stock markets and ASHAs.
BioNTech is now valued at $ 25.8 billion (€ 21.8 billion) versus Deutsche Bank, Germany’s largest lender.
(Except for the title, this story was not edited by NDTV staff and posted from a syndicated feed.)